Skip to main content
Premium Trial:

Request an Annual Quote

Bioinn to Distribute Courtagen's NGS Tests in Taiwan

NEW YORK (GenomeWeb) – Courtagen Life Sciences today announced a deal with Bioinn Molecular Diagnosis to provide Courtagen's clinical next-generation sequencing tests for neurological and metabolic disorders in Taiwan.

Courtagen's tests provide information on the genetic causes of disorders including epilepsy, intellectual disability, autism spectrum disorders, and mitochondrial dysfunction.

"The distribution agreement with Bioinn is another important step in the execution of our global strategy to support the increasing demand of our products," Courtagen President Brendan McKernan said in a statement. Financial and other terms of the deal were not disclosed.

Last month, Couragen and Sciencewerke signed an agreement for the international distribution of Courtagen's tests.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.